logo
Vaccination, immunity and records: Your questions on measles, answered

Vaccination, immunity and records: Your questions on measles, answered

CBC2 days ago
Social Sharing
Canada continues to see an alarming rise in measles cases in 2025.
Through the spring, the virus spread most intensely in Ontario. But after over 2,200 cases, hundreds hospitalized and one measles-related death, it seems to be dwindling in that province.
Now, Alberta's seeing a spike, with almost 1,300 confirmed cases so far.
With every province except Newfoundland and Labrador reporting cases of measles, here are some common questions from CBC readers, viewers and listeners — answered.
I've had measles as a child. Am I safe from getting infected again?
Most likely yes, says the Public Health Agency of Canada (PHAC).
It says those who have had a past measles infection should be immune against another one, as long as they have a normal immune response.
I've lost my vaccination records. Should I get another dose?
Generally, yes, says PHAC.
PHAC recommends that children and adults who don't have records of their vaccination history be started on an immunization schedule appropriate to their age and risk factors.
Even if you've already been vaccinated, it's generally considered safe for health-care providers to give another dose, PHAC says, because they haven't seen additional side effects from repeated immunization.
But this is why a national vaccine registry would be hugely helpful, says Dawn Bowdish, a professor of immunology at McMaster University.
"The number of people who are looking to figure out if they got one dose, if they got two doses, if they were vaccinated as children and perhaps they just moved provinces and they can't get their records is extremely high."
Two doses of the measles, mumps and rubella vaccine offer almost 100 per cent effectiveness against the virus in the long term.
Can I check my immunity to measles?
That depends.
PHAC says routine testing for laboratory evidence of measles immunity is not recommended for the general population.
Some populations, like health-care workers who work with vulnerable people, as well as some pregnant women, can get a blood test looking for antibodies against measles.
Those who have received two doses of a measles-containing vaccine, or those who are born before 1970, are presumed to be immune against the virus.
Do we screen for measles vaccination status among people who enter Canada?
No. Proof of vaccination is not mandatory to enter Canada.
Canada does require permanent residents and certain temporary residents to have an immigration medical exam before arriving in Canada, said a spokesperson for Immigration, Refugees and Citizenship Canada. The test also screens for certain communicable diseases.
During that medical exam, some may be offered vaccinations — including the measles, mumps and rubella shots.
Doctors who work with recent immigrants and asylum seekers tell CBC News their patients generally don't hesitate to get any childhood vaccinations they might have missed.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

CHAMPS Camp celebrates a decade of helping kids in Saskatchewan
CHAMPS Camp celebrates a decade of helping kids in Saskatchewan

CTV News

time21 minutes ago

  • CTV News

CHAMPS Camp celebrates a decade of helping kids in Saskatchewan

Ten years ago, a group of pediatric cardiology patient mothers saw a need for programming for their children. 'They recognized that there's no kind of rehab or physical activity program for children. There's lots in the adult world ... they decided that we needed some kind of programming for kids,' said Doctor Charissa Pockett, a pediatric cardiologist at Jim Patterson Children's Hospital and a member of the Mending Little Hearts Fund Group. That need created CHAMPS Camp, which offers opportunities for kids ages 4-17 with congenital or acquired heart disease to enjoy some physical activity. 'I get to see kids in hospital at their worst, and then I get to see them at camp doing amazing things that they never thought they could do, and especially families never thought they'd be able to do,' Pockett said. The program is celebrating a decade of success, and many of the families who took part in the camp gathered at Saskatoon's Gordie Howe Sports Complex to mark the occasion and talk about how it helped them. 'I just thought that I was the one kid who went and had surgeries done and procedures and all that stuff. And then when I finally came to camp in 2019, I felt like I was part of something, and I wasn't alone, and I was able to talk and learn about my heart,' Morgyn Moule said. CHAMPS Camp staff and families gathered at Saskatoon's Gordie Howe Sports Complex to celebrate a decade of success, Sunday, July 13 (Hallee Mandryk/CTV News) (Hallee Mandryk/CTV News) Morgyn's mother, Jennie, says the program has brought a lot of joy to many medical parents. 'It was nice to see her hang out with kids who experience the same heart conditions or different recognition, going to the doctor's office, going through procedures. It was nice to see her being with people with whom she felt like she belonged,' Jennie Moule said. 'They have rock climbing, swimming, playing games. It's just so great. I like it, and it's kind of fun ... to do stuff like that so kids can try new things,' nine-year-old Adaline Macpherson said. Organizers say kids with heart conditions are often discouraged or were previously unable to play sports or engage in physically demanding activities. The purpose of CHAMPS Camp is to allow kids to gain confidence in their abilities. The program also offers clinical psychology sessions for kids and their families. 'They go back to gym class and say, 'no, I can do this.' They want to participate. And it's really an amazing thing to see how lives have changed because of it,' Pockett said. Pockett says the program started off quite small but has remained successful over the years thanks to a lot of community support. 'The families and the patients who keep showing up year after year with a lot of enthusiasm who trust us with their children ... there's been lots of local businesses that have sponsored us ... the volunteers have been essential in helping the camp run and be successful,' Pockett said. The pediatric cardiologist says her hope to see the program expand outside of Saskatchewan. 'It's not just affecting the lives of kids in Saskatchewan but it's actually helping shape and educate our field as far as how to get kids physically active, especially when they've had congenital heart disease and have had heart surgeries,' Pockett said. The past ten years have certainly proved that there is a need for programs like CHAMPS Camp, which is something Pockett will be the first person to attest to. 'Watching kids gain that confidence, be able to really live healthy lives and be the best that they can be, and then carry that through to throughout the years... It's just a weeklong summer camp, but really, I get to see that when they come to their appointments and checkups, they live that day-to-day in their regular lives,' Pockett said.

Canadians could get more affordable version of Ozempic in early 2026. Here's how
Canadians could get more affordable version of Ozempic in early 2026. Here's how

CBC

time28 minutes ago

  • CBC

Canadians could get more affordable version of Ozempic in early 2026. Here's how

Social Sharing Cheaper versions of medications to treat obesity, like Ozempic and Wegovy, could be on the market in Canada as soon as January. Ozempic is a social media darling — with celebrities singing its praises and people posting about major weight loss. But a patient can pay $400 a month for such medications, says Dr. Sanjeev Sockalingam, Obesity Canada's scientific director and a professor of psychiatry at the University of Toronto. He says his patients have been frustrated and disappointed by the "prohibitive" cost. But now, several companies say they intend to market cheaper versions of such drugs. Here's what medical experts say: What are these medications? Injectable prescription drugs, sold as Ozempic and Wegovy, and the pill Rybelsus all contain the ingredient semaglutide. This class of medication, known as glucagon-like peptide-1 (GLP-1s), regulate blood sugar levels and appetite. Health Canada previously approved Ozempic to treat diabetes and Wegovy for weight loss. Nearly 33 per cent of Canadians (10.6 million people) were obese in 2023, according to a recent study. How much could the price come down? Novo Nordisk, maker of Ozempic and Wegovy, will effectively lose its price protection on those drugs in Canada in January, opening the door to generic versions. Mina Tadrous, an associate professor who evaluates pharmaceutical prices at the University of Toronto, says three or four companies have them in development or are starting the paperwork. Tadrous says the number of companies affects pricing. "The classic framework is that if you only have one, it comes down from the list price to 75 per cent," Tadrous said. "If we have two, it goes down to 50 per cent and if we have three it hits 25 per cent." Three manufacturers could bring the price down to $100 from $400 for the same strength of semaglutide product, Tadrous estimates. Have the generic medications been approved? Not yet. Health Canada needs to consider each company's application to make and sell generic versions of the injectable medication, known as a biosimilar. Since they won't require new clinical trials, they could be available within weeks of Health Canada's approval — "grandfathered" in, based on the original trials, says Sockalingam. "It's really about the equivalency of the medication in terms of its availability in the body and its metabolism." Will insurance cover them? Semaglutide is already listed on the Ontario drug formulary — a list of publicly covered medications for those over age 65, people living in long-term care homes, and for people receiving Ontario Works or disability payments. That means as soon as a generic form is available, those on public drug insurance plans could switch to it, and private insurance plans like those offered by employers likely will do the same, Tadrous says. Dr. Kaberi Dasgupta, a professor of medicine at McGill University and a researcher, says this would be good news for people who have excess weight and resulting complications but who can't currently afford the branded medications. Generic versions will "open the door for many more people," Dasgupta said. What's involved in taking these medications? Dasgupta says it's important for people taking semaglutide to have it prescribed by a physician and then monitored. "We should be insisting on having publicly accessible good diet and physical activity supports because we live in a society where people are gaining more and more weight," Dasgupta said. In England, for example, semaglutide is recommended with at least 13 hours of counselling on diet and physical activity. What about drug shortages? Because some medications also treat Type 2 diabetes, doctors and health-care policy experts continue to watch supply chains to prevent shortages. Dr. Harpreet Bajaj, an endocrinologist with LMC Healthcare in Brampton, Ont., recalls many times when patients with diabetes had to go off Ozempic or other GLP-1 medications because none was available. "Having a biosimilar, which is made by an entirely new pharmaceutical company and maybe … made in a more cost-effective way would also relieve some pressures on any future shortages that we might expect," Bajaj said. Dasgupta, who also treats diabetes, said in her experience in Quebec, sometimes the medication is more accessible through the province's publicly funded plan for those who fulfil the medical criteria than through some private insurers that focus more strongly on cost.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store